Results of the ADVISE II trial presented at TCT 2013

A new study supports the use of instantaneous wave-free ratio, to simplify assessment and determine the severity of coronary artery disease. ADVISE II findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

Fuente : http://www.eurekalert.org/pub_releases/2013-10/crf...